Plain-English translation of NCT07216508 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a liver transplant, some patients develop high blood sugar levels, which may affect how well the new liver works. This study uses a small sensor worn on your skin to continuously track your blood sugar patterns after you leave the hospital. The goal is to understand whether blood sugar control in the weeks and months after transplant impacts your long-term transplant outcomes.
Doctors know that high blood sugar after transplant can be a problem, but they don't have clear information about what happens to blood sugar in the real world after patients go home. This study will help doctors understand the connection between blood sugar control and transplant success, so they can develop better strategies to help future transplant patients.
You likely qualify if…
You likely don't qualify if…
You would wear a small, blinded glucose sensor for up to 30 days after you leave the hospital—this sensor measures your blood sugar throughout the day and night. The sensor data will be reviewed by the research team after you wear it, and they can share the results with you and your doctors. You would be asked to wear another sensor at 6 months and again at 12 months after your transplant to see how your blood sugar patterns change over time.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Enrollment target
~40 participants
Started
October 2025
Primary completion
October 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Grenye O'Malley
Icahn School of Medicine at Mount Sinai
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.